Acular PF Related Published Studies
Well-designed clinical trials related to Acular PF (Ketorolac Tromethamine Ophthalmic)
Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. [2011]
Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial. [2010.12]
Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. [2010.05]
Use of Acular LS in the pain management of keratoconus: a pilot study. [2010.02]
Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. [2009.06]
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]
Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial. [2009.02]
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. [2008.09]
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. [2007.07]
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]
Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]
Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. [2006.08]
The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial. [2006.05]
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]
Well-designed clinical trials possibly related to Acular PF (Ketorolac Tromethamine Ophthalmic)
Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized,
double-masked, placebo-controlled clinical trial. [2014]
Other research related to Acular PF (Ketorolac Tromethamine Ophthalmic)
Can topical ketorolac 0.5% improve the function of Ahmed(R) glaucoma drainage devices? [2011.05]
Keratitis and corneal melt with ketorolac tromethamine after conductive keratoplasty. [2011.04]
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. [2011]
Inhibition of choroidal neovascularization by intravitreal ketorolac. [2010.05]
Penetration of topically applied diclofenac and ketorolac into the aqueous humour
and subretinal fluid: randomized clinical trial. [2010]
Efficacy and tolerability of preservative-free and preserved diclofenac and
preserved ketorolac eyedrops after cataract surgery. [2010]
Use of Acular LS in the pain management of keratoconus: a pilot study. [2010]
Ketorolac tromethamine formulations: an overview. [2009.09]
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. [2008.04]
Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. [2007.07]
[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%] [2006.04]
Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. [2006.02]
An update on the use of ophthalmic ketorolac tromethamine 0.4%. [2006.01]
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. [2005.11]
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. [2005.01.25]
Other possibly related research studies
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. [2006.02]
Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). [2007.11]
[Efficacy observation of 0.1% bromfenac sodium eye drops on relieving the
post-LASEK irritative symptoms]. [Article in Chinese] [2015]
|